GRFS

Q: What is the price of Grifols (GRFS) today?

The price of Grifols (GRFS) today is R$ 53,81, with a variation of 10.82% compared to the last year. The price of Grifols (GRFS) started the year trading around R$ 39,88 and today it is at R$ 53,81. Follow the real-time price chart, the historical price of Grifols (GRFS), and stock data from Ibovespa and international markets.

Q: When does Grifols (GRFS) pay dividends?

Grifols (GRFS) did not distribute dividends in the last year.

Q: Grifols (GRFS) is it worth it?

Currently, Grifols (GRFS) is priced at R$ 53,81, with a P/E of 17,47%, representing a deviation of 24,01% from its historical average P/E. In the last year, the stock showed a variation of 10.82% in its price and distributed R$ 0,00 in dividends, resulting in a Dividend Yield of 1,71%. The total shareholder return was 10,82%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How to buy stocks of Grifols (GRFS)?

Investing in stocks of Grifols (GRFS) can be done in two ways: by buying the stock abroad or the BDR in Brazil (if available). The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much do 100 stocks of Grifols (GRFS) yield today?

The yield of Grifols (GRFS) was -3,71% in the last month, 10,82% in the last year and -35,93% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of R$ 0,93 in dividends, um Dividend Yield de 1,71%.If you wanted to buy 100 stocks of Grifols (GRFS) today, the total investment would be R$ 5.381,44, based on the current price of R$ 53,81.If past performance were to repeat, the return on your investment would be:In 1 year: R$ 5.963,71In 5 years: R$ 3.447,89In 10 years: 3.854,73It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Grifols S.A.

Price

US$ 10,04

variation (12m)

10,82%

p/l

17,47

p/vp

0,80

DIVIDEND YIELD

1,71%

price GRFS

BVMF

GRFS

If you had invested

years ago

6 months

1 year

5 years

10 years

today you would have

today you would have:

*The figure considers the reinvestment of dividends.

profitability of GRFS

1 month

3 months

1 year

2 years

5 years

10 years

profitability

1 month

-3,71%

3 months

15,07%

1 year

10,82%

2 years

4,58%

5 years

-35,93%

10 years

-28,37%

real profitability

profitability minus inflation.

1 month

-3,71%

3 months

14,90%

1 year

5,88%

2 years

-4,32%

5 years

-52,83%

10 years

-57,26%

Indicators GRFS

check out the fundamentals of Grifols shares

P/E

17,47

Sector: -3,15 Industry: -3,15

P/SALES RATIO (PSR)

0,83

Sector: -4,36 Industry: -4,36

P/BV

0,80

Sector: 1,77 Industry: 1,77

DIVIDEND YIELD (DY)

1,71%

Sector: - Industry: -

ROA

1,75%

Sector: -63,23% Industry: -63,23%

ROE

4,56%

Sector: -69,95% Industry: -69,95%

ROIC

5,75%

Sector: -2.093,52% Industry: -2.093,52%

NET MARGIN

4,75%

Sector: -41,50% Industry: -41,50%

GROSS MARGIN

39,48%

Sector: 38,30% Industry: 38,30%

OPERATING MARGIN

18,53%

Sector: -40,80% Industry: -40,80%

P/EBITDA

3,90

Sector: -3,30 Industry: -3,30

P/EBIT

4,60

Sector: -3,30 Industry: -3,30

P/ASSET

0,31

Sector: 1,31 Industry: 1,31

BVPS

12,72

Sector: 1,82 Industry: 1,82

EPS

0,58

Sector: -2,18 Industry: -2,18

EQUITY / ASSETS

0,38

Sector: 0,42 Industry: 0,42

CAGR REVENUES 5 YEARS

5,84%

Sector: - Industry: -

CAGR PROFITS 5 YEARS

-13,55%

Sector: - Industry: -

FAIR PRICE OF Grifols ASSETS ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Price

The Fair Price formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffet's mentor.

Current price

US$ 10,04

Fair Price

US$ 0,00

Upside Potencial de rentabilidade.

28,33%

See Graham's ranking

Because it considers equity value in its calculation, the formula does not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

GRFS indicators history

DRAG THE FRAME TO SEE MORE DATA

comparator of Stocks

DRAG THE FRAME TO SEE MORE DATA

	p/l	p/vp	ROE	dy	market value	net margin
JNJ	16,71	5,43	32,50%	2,83%	US$ 426,17 B	27,75%
PFE	15,38	1,59	10,33%	6,87%	US$ 141,44 B	15,13%
ABBV	100,08	-2.728,87	-2.726,81%	3,04%	US$ 376,58 B	6,45%
NVO	15,01	9,45	62,99%	3,05%	US$ 245,59 B	34,74%
MRK	11,91	4,29	36,03%	3,81%	US$ 210,57 B	28,16%
AZN	27,19	5,65	20,79%	2,53%	US$ 253,27 B	16,23%
BMY	18,63	5,49	29,44%	5,22%	US$ 95,93 B	10,71%
GILD	20,41	7,31	35,82%	2,71%	US$ 143,24 B	24,71%
ZTS	25,77	13,71	53,20%	1,26%	US$ 68,23 B	28,00%
HALO	15,49	27,25	175,93%	0,00%	US$ 9,07 B	48,21%
REGN	13,35	2,01	15,06%	0,46%	US$ 60,20 B	31,83%
AMGN	29,23	20,54	70,29%	2,47%	US$ 152,60 B	14,67%
VRTX	28,08	5,93	21,11%	0,00%	US$ 101,80 B	31,22%
ADMA	19,62	10,21	52,03%	0,00%	US$ 4,07 B	43,51%
MCK	23,18	-99,57	-429,55%	0,41%	US$ 85,93 B	0,97%
CAH	25,72	-13,51	-52,54%	1,36%	US$ 35,60 B	0,60%
BIIB	11,64	1,17	10,08%	0,00%	US$ 20,68 B	17,46%

comparison of GRFS with indexes

If you had invested (change) 2 years years ago, today you would have

R$ 1.000,00 in PETR4 you would have R$ 2.294,60

R$ 1.000,00 in LEVE3 you would have R$ 5.240,60

*The value considers the reinvestment of dividends.

dividend history GRFS dividend history

current DY: 1,71%

5-year average DY: 1,02%

DRAG THE FRAME TO SEE MORE DATA

type	date with	payment date	value
Dividends	12/08/2025	20/08/2025	0,17340000
Dividends	04/06/2021	14/06/2021	0,43850000
Dividends	02/11/2020	09/11/2020	0,20140000
Dividends	03/12/2019	11/12/2019	0,22190000
Dividends	10/06/2019	18/06/2019	0,16420000
Dividends	03/12/2018	11/12/2018	0,22780000
Dividends	04/06/2018	12/06/2018	0,25100000
Dividends	04/12/2017	12/12/2017	0,21270000
Dividends	01/06/2017	08/06/2017	0,16330000
Dividends	07/12/2016	14/12/2016	0,19340000
Dividends	06/06/2016	15/06/2016	0,16190000
Dividends	14/12/2015	17/12/2015	0,19220000
Dividends	10/06/2015	15/06/2015	0,16560000
Dividends	08/12/2014	12/12/2014	0,15450000
Dividends	09/06/2014	13/06/2014	0,14350000
Dividends	07/06/2013	13/06/2013	0,13040000
Dividends	28/05/2013	05/06/2013	0,00650000

ABOUT THE COMPANY Grifols

Grifols S.A.

Average user rating I10

4.0 (2 people)

Estados Unidos

38 years

Foundation: 1987

2011

Year of debut on the stock exchange - 14 years

23.655

Employees

The Company Grifols S.A. (Estados Unidos), is listed on Nasdaq with a market value of $ 6,98 Billions, having a net worth of $ 8,76 Billions.

With a total of 23.655 employees, the company is listed in the sector of Health Care and categorized in industry of Biotechnology.

In the last 12 months the Company had a revenue of $ 8,42 Billions, which generated a profit in the amount of $ 399,63 Milhões.

As for its main indicators, the Company has a P/E ratio of 17,47, a P/BV ratio of 0,80 and in the last 12 months the dividend yield of GRFS was at 1,71%.

The Company is traded internationally through the ticker GRFS.

Market value

US$ 6,98 Billions

Net worth

US$ 8,76 Billions

US$ 8.763.730.000,00

Assets

US$ 22,80 Billions

US$ 22.799.490.000,00

Total Number of Shares

689,00 Milhões

689.000.000

Average Daily Trading Volume

US$ 1,01 Million

US$ 1.006.356,76

Sector

Health Care

Industry

Biotechnology

GRFS

GRFS revenue and profits

GRFS results

DRAG THE FRAME TO SEE MORE DATA

GRFS cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

US$ - -0,00% (12M)

P/L

0,00

0,00%

ROE

-893,55%

P/VP

0,00

MCK - McKesson

US$ 719,80 41,62% (12M)

P/L

23,18

0,41%

ROE

-429,55%

P/VP

-99,57

CAH - Cardinal Health

US$ 152,47 38,27% (12M)

P/L

25,72

1,36%

ROE

-52,54%

P/VP

-13,51

JNJ - Johnson & Johnson

US$ 178,50 11,92% (12M)

P/L

16,71

2,83%

ROE

32,50%

P/VP

5,43

MRK - Merck & Co.

US$ 85,15 --22,88% (12M)

P/L

11,91

3,81%

ROE

36,03%

P/VP

4,29

ABBV - AbbVie

US$ 220,22 17,56% (12M)

P/L

100,08

3,04%

ROE

-2.726,81%

P/VP

-2.728,87

PFE - Pfizer

US$ 24,86 --9,07% (12M)

P/L

15,38

6,87%

ROE

10,33%

P/VP

1,59

AZN - AstraZeneca

US$ 81,10 4,90% (12M)

P/L

27,19

2,53%

ROE

20,79%

P/VP

5,65

BFRA - Biofrontera

US$ - -0,00% (12 M)

P/L

0,00

0,00%

ROE

-893,55%

P/VP

0,00

MCK - McKesson

US$ 719,80 41,62% (12 M)

P/L

23,18

0,41%

ROE

-429,55%

P/VP

-99,57

CAH - Cardinal Health

US$ 152,47 38,27% (12 M)

P/L

25,72

1,36%

ROE

-52,54%

P/VP

-13,51

JNJ - Johnson & Johnson

US$ 178,50 11,92% (12 M)

P/L

16,71

2,83%

ROE

32,50%

P/VP

5,43

MRK - Merck & Co.

US$ 85,15 --22,88% (12 M)

P/L

11,91

3,81%

ROE

36,03%

P/VP

4,29

ABBV - AbbVie

US$ 220,22 17,56% (12 M)

P/L

100,08

3,04%

ROE

-2.726,81%

P/VP

-2.728,87

PFE - Pfizer

US$ 24,86 --9,07% (12 M)

P/L

15,38

6,87%

ROE

10,33%

P/VP

1,59

AZN - AstraZeneca

US$ 81,10 4,90% (12 M)

P/L

27,19

2,53%

ROE

20,79%

P/VP

5,65

Common Questions

What is the price of Grifols (GRFS) today?

The price of Grifols (GRFS) today is R$ 53,81, with a variation of 10.82% compared to the last year. The price of Grifols (GRFS) started the year trading around R$ 39,88 and today it is at R$ 53,81. Follow the real-time price chart, the historical price of Grifols (GRFS), and stock data from Ibovespa and international markets.

When does Grifols (GRFS) pay dividends?

Grifols (GRFS) did not distribute dividends in the last year.

Grifols (GRFS) is it worth it?

Currently, Grifols (GRFS) is priced at R$ 53,81, with a P/E of 17,47%, representing a deviation of 24,01% from its historical average P/E. In the last year, the stock showed a variation of 10.82% in its price and distributed R$ 0,00 in dividends, resulting in a Dividend Yield of 1,71%. The total shareholder return was 10,82%.

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

How to buy stocks of Grifols (GRFS)?

Investing in stocks of Grifols (GRFS) can be done in two ways: by buying the stock abroad or the BDR in Brazil (if available). The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.

BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

How much do 100 stocks of Grifols (GRFS) yield today?

The yield of Grifols (GRFS) was -3,71% in the last month, 10,82% in the last year and -35,93% in the last 5 years (already considering appreciation and dividends).

In the last 12 months, the company paid a total of R$ 0,93 in dividends, um Dividend Yield de 1,71%.

If you wanted to buy 100 stocks of Grifols (GRFS) today, the total investment would be R$ 5.381,44, based on the current price of R$ 53,81.

If past performance were to repeat, the return on your investment would be:

In 1 year: R$ 5.963,71
In 5 years: R$ 3.447,89
In 10 years: 3.854,73

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

GRFS

Grifols S.A.

Price

variation (12m)

p/l

p/vp

DIVIDEND YIELD

profitability of GRFS

check out the fundamentals of Grifols shares

P/E

P/SALES RATIO (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

P/EBITDA

P/EBIT

P/ASSET

BVPS

EPS

EQUITY / ASSETS

CAGR REVENUES 5 YEARS

CAGR PROFITS 5 YEARS

Graham's Fair Price

If you had invested (change) 2 years years ago, today you would have

current DY: 1,71%

5-year average DY: 1,02%

type

date with

payment date

value

ABOUT THE COMPANY Grifols

Grifols S.A.

Estados Unidos

38 years

2011

23.655

PROFIT X PRICE GRFS

GRFS results

GRFS cash flow

evolution of assets - GRFS

GRFS balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

ABBV - AbbVie

PFE - Pfizer

AZN - AstraZeneca

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

ABBV - AbbVie

PFE - Pfizer

AZN - AstraZeneca

Common Questions

Tudo que o investidor precisa em um só lugar

Pague 2, Leve 3

Anual

Valor total R$ 238,80